Suppr超能文献

1 型神经纤维瘤病伴神经丛神经纤维瘤对英国成年患者及其照护者健康相关生活质量和工作生产力的影响:一项横断面调查。

Impact of neurofibromatosis type 1 with plexiform neurofibromas on the health-related quality of life and work productivity of adult patients and caregivers in the UK: a cross-sectional survey.

机构信息

Alexion, AstraZeneca Rare Disease, Cambridge, UK.

Costello Medical, London, UK.

出版信息

BMC Neurol. 2023 Nov 23;23(1):419. doi: 10.1186/s12883-023-03429-7.

Abstract

BACKGROUND

Plexiform neurofibromas (PN) are complex, benign nerve-sheath tumours that occur in 30-50% of patients with neurofibromatosis type 1 (NF1), a rare, genetic disorder. PN are associated with substantial, heterogeneous morbidities that impact health-related quality of life (HRQoL), including affecting motor function and causing pain, though HRQoL and work productivity data are scarce. This UK cross-sectional study explored HRQoL and work productivity in adult patients with NF1 PN and caregivers of paediatric patients.

METHODS

Adult patients and caregivers of paediatric patients self-enrolled in an online survey (March-April 2021). Outcomes included EQ-5D-5L, PROMIS® GH and INF1-QOL (adult patients only), and EQ-5D-5L, CarerQol and WPAI (caregivers only). Utilities were estimated from EQ-5D-5L responses using the UK crosswalk value set. Linear regression models explored univariable associations between adult patient characteristics and HRQoL.

RESULTS

Mean (± standard deviation) EQ-5D utility in adult patients with NF1 PN was 0.65 (± 0.29; n = 35; age-/sex-matched norm: 0.89 [± 0.04]). Moderate-extreme pain/discomfort and anxiety/depression were reported by 14/35 (40.0%) and 18/35 (51.4%) patients, respectively. Mean PROMIS® GH physical and mental health scores were 43.6 (± 9.19) and 41.7 (± 11.5; n = 35; matched norm: 50.0 [± 10.0]). Mean INF1-QOL score was 11.03 (± 6.02; n = 33). Chronic itching, at least one symptom, at least one comorbidity, PN location at extremities (arms/legs) and pain were associated with worse HRQoL scores. Mean caregiver EQ-5D utility was 0.72 (± 0.24; n = 8; age-/sex-matched norm: 0.88 [± 0.03]). Moderate pain/discomfort and moderate-severe anxiety/depression were reported by 4/8 (50.0%) and 2/8 (25.0%) caregivers, respectively. Mean CarerQol score was 69.3 (± 13.9; n = 8). Mean WPAI regular activity productivity loss was 36.3% (± 31.6%; n = 8).

CONCLUSIONS

NF1 PN worsens adult patient and caregiver HRQoL compared to the general population, notably affecting pain and discomfort, anxiety and depression and caregiver productivity.

摘要

背景

丛状神经纤维瘤(PN)是一种复杂的良性神经鞘瘤,发生于 30-50%的神经纤维瘤病 1 型(NF1)患者中,这是一种罕见的遗传性疾病。PN 与大量异质的发病率相关,这些发病率会影响健康相关生活质量(HRQoL),包括影响运动功能和引起疼痛,尽管 HRQoL 和工作生产力数据很少。这项英国横断面研究探讨了 NF1 PN 成年患者和儿科患者照顾者的 HRQoL 和工作生产力。

方法

成年患者和儿科患者的照顾者自行参加了一项在线调查(2021 年 3 月至 4 月)。结果包括 EQ-5D-5L、PROMIS® GH 和 INF1-QOL(仅成年患者),以及 EQ-5D-5L、CarerQol 和 WPAI(仅照顾者)。使用英国交叉评估值集从 EQ-5D-5L 反应中估计效用。线性回归模型探讨了成年患者特征与 HRQoL 之间的单变量关联。

结果

NF1 PN 成年患者的平均(±标准差)EQ-5D 效用为 0.65(±0.29;n=35;年龄/性别匹配的标准值:0.89 [±0.04])。14/35(40.0%)和 18/35(51.4%)患者分别报告有中度至重度疼痛/不适和焦虑/抑郁。平均 PROMIS® GH 生理和心理健康评分分别为 43.6(±9.19)和 41.7(±11.5;n=35;匹配标准值:50.0 [±10.0])。INF1-QOL 评分的平均值为 11.03(±6.02;n=33)。慢性瘙痒、至少一种症状、至少一种合并症、PN 位于四肢(手臂/腿部)和疼痛与较差的 HRQoL 评分相关。平均照顾者 EQ-5D 效用为 0.72(±0.24;n=8;年龄/性别匹配的标准值:0.88 [±0.03])。4/8(50.0%)和 2/8(25.0%)照顾者分别报告有中度疼痛/不适和中度至重度焦虑/抑郁。平均 CarerQol 评分为 69.3(±13.9;n=8)。平均 WPAI 常规活动生产力损失为 36.3%(±31.6%;n=8)。

结论

NF1 PN 与一般人群相比,会降低成年患者和照顾者的 HRQoL,特别是影响疼痛和不适、焦虑和抑郁以及照顾者的生产力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdd3/10666383/40ff935efdee/12883_2023_3429_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验